Invokana Lawsuit Connects Diabetes Drug To Possible Side Effects Including Kidney Failure

March 31, 2016 – – TheProductLawyers.com reports on recent allegations surrounding type-2 diabetes drug Invokana, which link the use of the drug to possibly severe kidney risks. The U.S. Food and Drug Administration states that they have received 50 reports of adverse events concerning patients who have used Invokana and have developed renal impairment and kidney failure in the drug’s initial year on the market alone.

Invokana was approved by the FDA in March of 2013 as a new-generation type-2 diabetes medication. It is one of a group of similar drugs released known as SGLT2 class inhibitors, which is an abbreviation for sodium-glucose cotransporter-2. The drug works by helping type-2 diabetes patients to maintain their glucose or blood sugar levels. It accomplishes this by preventing the kidneys from absorbing excess sugar and instead ridding the body of that excess sugar through urination.

Working in this fashion means that Invokana relies heavily on the kidneys, which may also mean that it can pose a serious health risk for those organs, especially among patients who have pre-existing kidney damage, which can be a common side effect of diabetes. The announcement of this potential side effect has understandably caused concern among those currently relying on Invokana or another SGLT2 class inhibitor drug to help manage their diabetes.

The attorneys of Banville Law understand the importance of keeping the public informed of the latest updates concerning potential side effects such as these. They work daily to provide the public with current information on Invokana and other similar SGLT2 class inhibitor drugs. To accomplish this, they sponsor the online resource website TheProductLawyers.com, and are also currently helping anyone who has used these drugs and has suffered from medical complications that they believe were caused by the drugs. These individuals deserve the important opportunity to fully explore their legal rights in the matter. Affected patients could be entitled to substantial compensation attained through legal action. To assist those looking at the possibility of legal action, the attorneys of Banville Law are also currently offering free legal consultations for qualified individuals.

To ask questions regarding Invokana lawsuits, or to request additional information on SGLT2 class inhibitor drugs, please contact the attorneys of Banville Law by calling 877-671-6480.

###

Contact TheProductLawyers.com:

Banville Law
877-671-6480
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009001